Project Grant K23MH139637
- The National Institute of Mental Health (NIMH) awarded a $1,199,261 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Ampa Inc. The grant, awarded on September 15, 2025, will fund the development of a next-generation Transcranial Magnetic Stimulation (TMS) system that aims to make highly effective, personalized depression treatment more accessible and scalable. The key innovations include precision TMS targeting using neurocardiac response signals, camera-based...
- This federal Project Grant award of $498,429, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to identify the key factors that determine an individual's response to transcranial direct current stimulation (tDCS). The research aims to apply machine learning algorithms to a large, multimodal dataset of over 225 tDCS-fMRI sessions to determine which factors, such as baseline task performance, brain...
- The National Institute of Mental Health (NIMH) awarded a $830,409 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System, to develop novel software and computational techniques that integrate real-time navigated electric-field mapping and source-space electroencephalogram (EEG) analysis during transcranial magnetic stimulation (TMS) to improve the accuracy of targeting and dosimetry for...
- This federal Project Grant award of $777,016.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports a study on the synaptic mechanisms underlying repetitive transcranial magnetic stimulation (rTMS) protocols for the treatment of treatment-resistant depression. The study, titled "Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression," aims to investigate the neural mechanisms of the inhibitory...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $778,548 to support research on the neural mechanisms underlying social cognitive deficits in schizophrenia. The awardee, the Research Foundation for Mental Hygiene, Inc. through its Nathan S. Kline Institute Division, will utilize multimodal neuroimaging approaches, including ERP, fMRI, and transcranial direct current stimulation, to investigate...
- The National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), awarded a $127,305 Project Grant to the Icahn School of Medicine at Mount Sinai to investigate the role of frontal parvalbumin interneuron maturation in the development of attention. The award, effective May 2, 2025 through April 30, 2027, will fund research to characterize the neural circuit mechanisms of frontal cortex maturation essential for cognitive function, with the goal of...
- The National Institute of Mental Health (NIMH) awarded a $156,500 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Emory University to identify patients with true treatment failure for major depressive disorder (MDD) who may benefit from earlier referral to alternative treatments like transcranial magnetic stimulation, ketamine, and vagus nerve stimulation. The project aims to use trajectory classification methods to empirically separate partial response from true...
- This Project Grant award, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to establish reliable markers of prefrontal excitability that can be used to optimize repetitive transcranial magnetic stimulation (rTMS) treatment for depression. The $784,096 award, with a project period from May 1, 2025 to February 28, 2030, will allow researchers at The Leland Stanford Junior University to: 1) investigate how...
- This federal Project Grant award of $147,486 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to advance the understanding of negative symptoms, cognition, and functional connectivity in psychotic disorders and mood disorders with psychosis. The key objectives are to: (A) investigate whether ecological momentary symptom assessment and mobile cognitive testing reveal stronger relationships between motivational/pleasure...
- This federal Project Grant award, titled "MAINTENANCE RTMS FOR DEPRESSION (MAITR-DE)", is funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $968,769 award will support a multi-site study to investigate the efficacy of maintenance repetitive transcranial magnetic stimulation (rTMS) in sustaining treatment response for individuals with treatment-resistant depression. The study will be conducted by the University of...
This National Institute of Mental Health (NIMH) Career Development Award (CFDA 93.242 - Mental Health Research Grants) will provide $188,976 to support a project led by Dr. Drew Winters at the University of Colorado School of Medicine. The project aims to test whether transcranial magnetic stimulation (TMS) can improve social cognition, cognitive processing, and functional brain architecture in adults with psychopathy. The study will enroll 60 participants ages 18-60 and evaluate the effects of inhibitory TMS to the right dorsolateral prefrontal cortex and excitatory TMS to the right temporoparietal junction. The award period runs from September 12, 2025 to August 31, 2030. The research protocol and training plan are designed to help launch Dr. Winters' career as an independent scientist focused on understanding the neural mechanisms underlying social cognition and cognitive processing in psychopathy, as well as developing novel treatment approaches.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/17/25 | ||
| Not listed | $189.0k | 9/12/25 |